Dr. Malhi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
101 Bodin Cir
Travis AFB, CA 94535Phone+1 707-423-5129Fax+1 707-423-5137
Education & Training
- Cleveland Clinic FoundationFellowship, Hematology and Medical Oncology, 2001 - 2004
- Cleveland Clinic Foundation/Fairview HospitalResidency, Internal Medicine, 1998 - 2001
- Government Medical College AmritsarClass of 1996
Certifications & Licensure
- CA State Medical License 2014 - 2026
- WA State Medical License 2004 - 2016
- OH State Medical License 2000 - 2006
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Publications & Presentations
PubMed
- 8 citationsPhase I trial of thalidomide and interleukin-2 in patients with metastatic renal cell carcinoma.Thomas Olencki, Sareena Malhi, Tarek Mekhail, Robert Dreicer, Paul Elson
Investigational New Drugs. 2006-01-28 - 53 citationsExpression of bcl-2 in Classical Hodgkin's Lymphoma: An Independent Predictor of Poor OutcomeStephen J. Sup, Carlos Alemany, Brad Pohlman, Paul Elson, Serena Malhi
Journal of Clinical Oncology. 2005-06-01 - 417 citationsValidation and Extension of the Memorial Sloan-Kettering Prognostic Factors Model for Survival in Patients With Previously Untreated Metastatic Renal Cell CarcinomaTarek Mekhail, Rony M. Abou-Jawde, Gabriel BouMerhi, Sareena Malhi, Laura S. Wood
Journal of Clinical Oncology. 2005-02-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: